Home
>
National Drug Code (NDC)
>
RAMIPRIL
RAMIPRIL - 17856-0108-2 - (RAMIPRIL)
Drug Information of RAMIPRIL
| Product NDC: | 17856-0108 |
| Proprietary Name: | RAMIPRIL |
| Non Proprietary Name: | RAMIPRIL |
| Active Ingredient(s): | 5 mg/1 & nbsp; RAMIPRIL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RAMIPRIL
| Product NDC: | 17856-0108 |
| Labeler Name: | Atlantic Biologicals Corps |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077900 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080618 |
Package Information of RAMIPRIL
| Package NDC: | 17856-0108-2 |
| Package Description: | 1 CAPSULE in 1 DOSE PACK (17856-0108-2) |
NDC Information of RAMIPRIL
| NDC Code | 17856-0108-2 |
| Proprietary Name | RAMIPRIL |
| Package Description | 1 CAPSULE in 1 DOSE PACK (17856-0108-2) |
| Product NDC | 17856-0108 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RAMIPRIL |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080618 |
| Marketing Category Name | ANDA |
| Labeler Name | Atlantic Biologicals Corps |
| Substance Name | RAMIPRIL |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
